v3.26.1
CAPITAL STRUCTURE (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 04, 2025
Feb. 06, 2025
Jan. 06, 2025
Dec. 23, 2024
Nov. 02, 2024
Sep. 04, 2024
Jul. 31, 2024
Jun. 13, 2024
Dec. 28, 2023
Sep. 30, 2023
Mar. 31, 2026
Dec. 31, 2025
Sep. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Dec. 31, 2025
Jul. 25, 2025
Class of Stock [Line Items]                                  
Common Stock, Shares Authorized                     150,000,000 150,000,000       150,000,000  
Common stock, par value                     $ 0.0001 $ 0.0001       $ 0.0001  
Preferred stock authorized                     10,000,000 10,000,000       10,000,000  
Preferred stock, par value                     $ 0.0001 $ 0.0001       $ 0.0001  
Common stock, shares outstanding                     6,553,996 5,746,948       5,746,948  
Treasury stock                     $ 0 $ 0       $ 0  
Proceeds from sale of preferred stock                     0     $ 5,330,000      
Subscription receivable                     3,653,456 3,686,544       $ 3,686,544  
Stock-based compensation expense                     1,079,436            
Unamortized stock-based compensation                     0            
Stock issued for debt, value                     1,663,580            
Warrants issued for services                     0     824,295      
Proceeds subscriptions receivable                         $ 4,500,000        
Subscriptions receivable net                         $ 500,000        
Subscription Receivable Sept 2023 [Member]                                  
Class of Stock [Line Items]                                  
Stock issued for debt, value                   $ 2,100,000              
Stock Options [Member]                                  
Class of Stock [Line Items]                                  
Stock-based compensation expense                     1,416,178     597,731      
Consulting Agreement [Member]                                  
Class of Stock [Line Items]                                  
Subscription receivable                                 $ 125,000
Modification [Member]                                  
Class of Stock [Line Items]                                  
Stock-based compensation expense                     315,888            
Two Investor [Member]                                  
Class of Stock [Line Items]                                  
Gross proceeds                       $ 3,120,000          
Number of shares issued                       260,000          
Principal amount                     3,120,000            
Debt instrument stated percentage                       1.00%       1.00%  
Maturity period                       Dec. 18, 2026          
Subscriptions receivable net                       $ 3,120,000       $ 3,120,000  
Standby Equity Purchase Agreement [Member]                                  
Class of Stock [Line Items]                                  
Gross proceeds                     $ 504,254     $ 239,203      
Number of shares issued                     39,273     81,877      
Standby Equity Purchase Agreement [Member] | Yorkville [Member]                                  
Class of Stock [Line Items]                                  
Payment of commitment fee         $ 200,000                        
Standby Equity Purchase Agreement [Member] | Yorkville [Member] | Convertible Note [Member]                                  
Class of Stock [Line Items]                                  
Convertible notes outstanding         1,304,758                        
Standby Equity Purchase Agreement [Member] | Stock Issued For Services [Member] | Yorkville [Member]                                  
Class of Stock [Line Items]                                  
Payment of commitment fee         $ 80,000                        
SNAP Biosciences Inc [Member]                                  
Class of Stock [Line Items]                                  
Investors description                         In addition to the shares of common stock of the Company, investors also received 10% aggregate non-voting ownership in the Company’s subsidiary, SNAP Biosciences, Inc. Of this $5,000,000 raised, $4,500,000 was collected as of December 31, 2025. $500,000 of the subscription receivable is tied to a promissory note bearing 1% interest annum, with a maturity date of January 18, 2026        
Private Placement [Member]                                  
Class of Stock [Line Items]                                  
Proceeds from common stock                         $ 5,000,000        
Subscriptions receivable                         $ 5,000,000        
Common Stock [Member]                                  
Class of Stock [Line Items]                                  
Common stock, par value                     $ 0.0001            
Warrant Note Subscription Receivables [Member]                                  
Class of Stock [Line Items]                                  
Aggregate exercise price of warrant                 $ 1,100,000                
Series A Preferred Stock [Member]                                  
Class of Stock [Line Items]                                  
Preferred stock authorized                     10,000            
Number of shares issued               4,300                  
Preferred stock, shares issued                     0 0       0  
Preferred stock, shares outstanding                     0 0       0  
Proceeds from sale of preferred stock   $ 3,480,000   $ 695,000   $ 225,000 $ 1,300,000 $ 4,300,000                  
Conversion of stock, shares converted                               10,000  
Proceeds from issuance of preferred stock                             $ 125,000    
Subscription receivable                             $ 125,000    
Warrants issued for services                     $ 33,088            
Equity Incentive Plan 2022 [Member]                                  
Class of Stock [Line Items]                                  
Number of shares forfeited 87,375                                
Exercise price of warrants $ 10.52   $ 5.72                            
Number of shares expired     100,000